Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug ...

(Spencer Platt/Getty Images) The Centers for Disease Control and Prevention might soon limit its guidance for who should receive a coronavirus booster shot. Such a change would be evidence-based ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...

Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...

The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...

US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech ...

Novavax makes the nation's only traditional protein-based COVID-19 vaccine. It is still being sold under emergency use authorization -- unlike mRNA vaccines made by Pfizer and Moderna that have ...